நிகழ்வு சொத்து மேலாண்மை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிகழ்வு சொத்து மேலாண்மை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிகழ்வு சொத்து மேலாண்மை Today - Breaking & Trending Today

Cancer-fighting startup Turnstone Biologics raises US$80M series-D investment

One of Ottawa’s most highly-touted biotech startups has secured the city’s largest venture capital deal in nearly three years.
Turnstone Biologics was cofounded by three Ontario physicians including Dr. John Bell of the Ottawa Hospital and is developing cancer-fighting viruses. On Wednesday, the firm said it had completed a US$80-million series-D funding round led by PFM Health Sciences and Point72.
“This oversubscribed financing will allow us to advance our vision to benefit millions of cancer patients underserved by current treatment options,” said Turnstone president and CEO Sammy Farah in a statement.
Turnstone, which also maintains offices in New York, where Farah is based, and San Diego, has already raised more than $50 million as it develops groundbreaking treatments that use the body’s own immune system to battle cancer. The firm is widely regarded as a leader in the emerging field of immunotherapy, in which viruses that attack malignant tumours are a ....

New York , United States , San Diego , Sammy Farah , John Bell , Jm Family Enterprises , Health Sciences , Ottawa Hospital , Assent Compliance , Turnstone Biologic , Eventide Asset Management , Surveyor Capital , Ridgeback Capital Investments , Takeda Ventures , Caas Capital , Northleaf Capital Partners , Versant Ventures , F Prime Capital , Sectoral Asset Management , Sixty Degree Capital , Brace Pharma Capital , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , சமி ஃபரா , ஜான் மணி ,

Cancer-fighting startup Turnstone Biologics raises US$80M series-D investment

One of Ottawa’s most highly-touted biotech startups has secured the city’s largest venture capital deal in nearly three years.
Turnstone Biologics was cofounded by three Ontario physicians including Dr. John Bell of the Ottawa Hospital and is developing cancer-fighting viruses. On Wednesday, the firm said it had completed a US$80-million series-D funding round led by PFM Health Sciences and Point72.
“This oversubscribed financing will allow us to advance our vision to benefit millions of cancer patients underserved by current treatment options,” said Turnstone president and CEO Sammy Farah in a statement.
Turnstone, which also maintains offices in New York, where Farah is based, and San Diego, has already raised more than $50 million as it develops groundbreaking treatments that use the body’s own immune system to battle cancer. The firm is widely regarded as a leader in the emerging field of immunotherapy, in which viruses that attack malignant tumours are a ....

New York , United States , San Diego , Sammy Farah , John Bell , Jm Family Enterprises , Health Sciences , Ottawa Hospital , Assent Compliance , Turnstone Biologic , Eventide Asset Management , Surveyor Capital , Ridgeback Capital Investments , Takeda Ventures , Caas Capital , Northleaf Capital Partners , Versant Ventures , F Prime Capital , Sectoral Asset Management , Sixty Degree Capital , Brace Pharma Capital , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , சமி ஃபரா , ஜான் மணி ,

Kojin bags $60M to exploit weakness of drug-resistant cancers

Kojin Therapeutics has raised $60 million to use iron-dependent cell death to treat drug-resistant cancer. The series A round positions the biotech to build on the work its scientific founders did at institutions including Harvard University and Dana-Farber Cancer Institute. ....

Al Iskandariyah , Harvard Schreiber , Johnson Janssen , Abbvie Steve Davidsen , Benjamin Cravatt , Stephanie Dougan , Susan Langer , Dana Farber Dougan , Vasanthi Viswanathan , Stuart Schreiber , Kay Ahn , Polari Amir Nashat , Harvard University , Dana Farber Cancer Institute , Scripps Research Institute Cravatt , Cathay Health , Kojin Therapeutics , Dana Farber Cancer , Newpath Partners , Eventide Asset Management , Binney Street Capital , Scripps Research Institute , Chief Scientific Officer Kay Ahn , Dana Farber Cancer Institute , He Scripps Research Institute , Kojin Therapeutics ,

Kojin Therapeutics Debuts to Solve Difficult Diseases Through Cell Behavior

Published: Jun 09, 2021
By Mark Terry
Kojin Therapeutics
launched with a $60 million Series A to initially focus on oncology and cell state biology. The round was led by Polaris Partners, Newpath Partners, and Cathay Health, affiliated to Cathay Capital. Participants included Leaps by Bayer, AbbVie, Eventide Asset Management, Alexandria, the Dana-Farber Cancer Institute’s Binney Street Capital, and several family offices.
The approach came out of the
laboratoryof Stuart Schreiber, Harvard University professor and co-founder of the Broad Institute. Co-founders of Kojin include Benjamin Cravatt, Stephanie Dougan and Vasanthi Viswanathan. The company’s technology is ferroptosis-based drug discovery, which is to say, iron-dependent cell death. Kojin says that difficult-to-treat diseases, which includes drug-resistant cancers, involve diseased cells that are sensitive to ferroptosis. ....

United States , Al Iskandariyah , Harvard University , Dana Farber Cancer Institute , Jurgen Eckhardt , Amir Nashat , Benjamin Cravatt , Stephanie Dougan , Joel Barrish , Steve Davidsen , Nagesh Mahanthappa , Susan Langer , Vasanthi Viswanathan , Nortonb Gilula , Stuart Schreiber , Kay Ahn , Sean Morrison , Scripps Research Institute , Broad Institute , Sarcoma Center At Dana Farber , Harvard Medical School , Ludwig Center At Dana Farber Harvard Cancer , Cathay Health , Children Medical Center Research Institute , Department Of Chemistry , Schreiber Lab ,

Arch Oncology Raises $105M in Series C Financing

Arch Oncology Raises $105M in Series C Financing
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Laurence Blumberg , Joe Biller , Eric Pham , Arch Oncology Inc , Senior Research Analyst At Eventide Asset Management , Broadfin Holdings , Roche Venture Fund , Arch Oncology , Eventide Asset Management , Cowen Healthcare Investments , Adage Capital Management , Avego Healthcare Capital , Rivervest Venture Partners , Ajoy Ghosh , Senior Research Analyst , Managing Director , Chief Executive Officer , லாரன்ஸ் ப்ளம்பெர்க் , ஓஹோ பில்லர் , எரிக் ஃப்யாம் , வளைவு புற்றுநோயியல் இன்க் , ரோச் துணிகர நிதி , வளைவு புற்றுநோயியல் , நிகழ்வு சொத்து மேலாண்மை , கோவன் சுகாதாரம் முதலீடுகள் , முதுமொழி மூலதனம் மேலாண்மை ,